LAMP3
LAMP3 (Lysosomal Associated Membrane Protein 3), also known as DC-LAMP or CD208, is a protein that in humans is encoded by the LAMP3 gene. It is a member of the lysosome associated membrane protein (LAMP) family, which is characterized by a highly glycosylated luminal domain and a relatively short cytoplasmic tail.
Function[edit]
LAMP3 is primarily expressed in dendritic cells, where it is involved in the formation and maintenance of the endosomal compartment. It is also involved in the process of antigen presentation, which is crucial for the activation of the immune response. LAMP3 is also found in other cell types, including cancer cells, where it may play a role in tumor progression and metastasis.
Structure[edit]
The LAMP3 protein is a type I transmembrane protein, meaning it has a single transmembrane domain with its N-terminus on the outside of the cell and its C-terminus on the inside. The luminal domain of LAMP3 is heavily glycosylated, which is thought to protect the protein from degradation in the harsh environment of the lysosome.
Clinical significance[edit]
Alterations in the expression of LAMP3 have been associated with various diseases, including cancer, autoimmune diseases, and infectious diseases. In cancer, overexpression of LAMP3 has been linked to increased tumor aggressiveness and poor prognosis. In autoimmune diseases, LAMP3 may play a role in the presentation of self-antigens, leading to an inappropriate immune response. In infectious diseases, LAMP3 may be involved in the presentation of pathogen-derived antigens, leading to an immune response against the pathogen.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian